ORBITAL: Member of Dissemination, IP and Exploitation Sub-Committee
Dr. Hakkarainen received her Ph.D. in Biopharmacy in 2013 from the University of Eastern Finland, Kuopio, Finland. Dr. Hakkarainen has a strong research background in ex vivo and in vitro drug permeability testing and prediction of drug transport across biological barriers, such as cornea, blood-brain barrier, intestine, and skin. She contributes many years’ experience working with in vitro cell culture, using primary endothelial and secondary epithelial and glioma cell lines. She joined Experimentica Ltd., the leading preclinical CROs dedicated to drug discovery and development for ophthalmic disorders in 2014 and currently serves as a Chief Operating Officer.